{
  "name": "Fulgent Therapeutics, Llc.",
  "credentials": "",
  "specialty": "Clinical Laboratory",
  "city": "El Monte",
  "state": "CA",
  "entity_type": "Organization",
  "yearly_payments": [
    {
      "year": 2020,
      "total_payments": 2479369.68,
      "total_services": 25011,
      "total_beneficiaries": 15379,
      "avg_submitted": 246.67,
      "avg_paid": 57.94
    },
    {
      "year": 2021,
      "total_payments": 5714665.09,
      "total_services": 105378,
      "total_beneficiaries": 51947,
      "avg_submitted": 119.8,
      "avg_paid": 54.2
    },
    {
      "year": 2022,
      "total_payments": 8526491.39,
      "total_services": 174974,
      "total_beneficiaries": 40215,
      "avg_submitted": 101.33,
      "avg_paid": 40.78
    },
    {
      "year": 2023,
      "total_payments": 266310.79,
      "total_services": 5507,
      "total_beneficiaries": 2622,
      "avg_submitted": 136.33,
      "avg_paid": 45.33
    }
  ],
  "top_procedures": [
    {
      "code": "U0003",
      "description": "Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r",
      "services": 159629,
      "payments": 12518215.25,
      "avg_markup": 3.19
    },
    {
      "code": "U0005",
      "description": "Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within",
      "services": 133153,
      "payments": 3305008.5,
      "avg_markup": 2.82
    },
    {
      "code": "87636",
      "description": "Sarscov2 & inf a&b amp prb",
      "services": 5753,
      "payments": 851259.39,
      "avg_markup": 2.42
    },
    {
      "code": "G2023",
      "description": "Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source",
      "services": 10916,
      "payments": 255501.76,
      "avg_markup": 1.71
    },
    {
      "code": "87426",
      "description": "Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus",
      "services": 687,
      "payments": 23783.94,
      "avg_markup": 2.54
    },
    {
      "code": "0013A",
      "description": "Fee covid-19 vac 2 booster",
      "services": 251,
      "payments": 11068.26,
      "avg_markup": 1.81
    },
    {
      "code": "0003A",
      "description": "Fee covid-19 vac 1 booster",
      "services": 207,
      "payments": 9137.64,
      "avg_markup": 1.81
    },
    {
      "code": "0011A",
      "description": "Adm sarscov2 100mcg/0.5ml1st",
      "services": 73,
      "payments": 3291.57,
      "avg_markup": 1.77
    },
    {
      "code": "0012A",
      "description": "Adm sarscov2 100mcg/0.5ml2nd",
      "services": 73,
      "payments": 3291.57,
      "avg_markup": 1.77
    },
    {
      "code": "U0002",
      "description": "2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc",
      "services": 52,
      "payments": 2618.68,
      "avg_markup": 8.94
    },
    {
      "code": "87635",
      "description": "Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen",
      "services": 45,
      "payments": 2262.6,
      "avg_markup": 4.97
    },
    {
      "code": "0001A",
      "description": "Adm sarscov2 30mcg/0.3ml 1st",
      "services": 19,
      "payments": 856.71,
      "avg_markup": 1.77
    },
    {
      "code": "0002A",
      "description": "Adm sarscov2 30mcg/0.3ml 2nd",
      "services": 12,
      "payments": 541.08,
      "avg_markup": 1.77
    }
  ],
  "overall": {
    "years_active": 4,
    "total_payments": 16986836.95,
    "total_services": 310870,
    "total_beneficiaries": 110163,
    "avg_markup_ratio": 3.05
  }
}